| General strategy for the management of bronchial asthma in pregnancy. | |
| | |
MedLine Citation:
|
PMID: 12854627 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Epidemiological studies showed that bronchial asthma is one of the most common diseases which can complicate pregnancy (1-7%). In about 0.05-2% of the cases, asthma occurs as a life-threatening event. In the common medical practice a waiting strategy or, even, the complete refusal for drug therapies are frequently observed. This is justified by the fear of the possible adverse effects of drugs on developing fetus. On the contrary, several studies have demonstrated that severe and uncontrolled asthma may produce serious maternal and fetal complications, such as gestational hypertension and eclampsia, fetal hypoxemia and an increased risk of perinatal death. Therefore, all pregnant women suffering from bronchial asthma should be considered as potentially at high risk of complications and adequately treated. Since asthma is a chronic disease with acute exacerbations, a continuous treatment is mandatory to control symptoms, to prevent acute episodes and to reduce the degree of airway inflammation. The global strategy for asthma management in pregnancy includes five main topics: (1) objective evaluation of maternal/ fetal clinical conditions; (2) avoidance/control of triggering factors; (3) pharmacological treatment; (4) educational support; (5) psychological support. As far as drug therapy is concerned, the International Guidelines and Recommendations suggest that the general strategy does not differ significantly from management outside pregnancy. We herein review and discuss the available data and the criteria for the management of asthma in pregnant patients. |
| | |
Authors:
|
G Liccardi; M Cazzola; G W Canonica; M D'Amato; G D'Amato; G Passalacqua |
Related Documents
:
|
19087117 - Antiepileptic drugs during pregnancy: what is known and which aeds seem to be safest? 15035567 - Treatment of allergic rhinitis during pregnancy. 8192177 - Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and cl... 18929087 - Seizures in pregnancy: diagnosis and management. 23119197 - Ruptured noncommunicating rudimentary horn pregnancy at 19 weeks with previous cesarean... 9219277 - Prenatal diagnosis using fetal cells from the maternal circulation. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Respiratory medicine Volume: 97 ISSN: 0954-6111 ISO Abbreviation: Respir Med Publication Date: 2003 Jul |
Date Detail:
|
Created Date: 2003-07-11 Completed Date: 2003-08-04 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8908438 Medline TA: Respir Med Country: England |
Other Details:
|
Languages: eng Pagination: 778-89 Citation Subset: IM |
Affiliation:
|
Unit of Pneumology and Allergology, Department of Chest Diseases, A.Cardarelli Hospital, Piazza Arenella no 7/h, Naples 80128, Italy. gennaro.liccardi@tin.it |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adrenergic beta-Agonists
/
therapeutic use* Adult Androstadienes / contraindications Anesthesia, Local Anesthesia, Obstetrical Asthma / drug therapy*, psychology, therapy Bronchodilator Agents / therapeutic use* Chronic Disease Cromolyn Sodium / therapeutic use Female Glucocorticoids / therapeutic use Histamine H1 Antagonists / therapeutic use Humans Immunotherapy Obstetric Labor Complications / drug therapy Oxytocics / contraindications Patient Education as Topic Pregnancy Pregnancy Complications / drug therapy*, psychology, therapy Theophylline / adverse effects, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Adrenergic beta-Agonists; 0/Androstadienes; 0/Bronchodilator Agents; 0/Glucocorticoids; 0/Histamine H1 Antagonists; 0/Oxytocics; 15826-37-6/Cromolyn Sodium; 58-55-9/Theophylline; 90566-53-3/fluticasone |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year pro...
Next Document: Use of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysis.